3 completed, 1 withdrawn. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Withdrawn 1 |
Follow Plasma Cell Neoplasm: new trials by email Literature Review of Plasma Cell Neoplasm trials Research Report on Plasma Cell Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2012-05-01 | 2012-07-09 | |
| High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors etoposide, cyclophosphamide, carmustine - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Not applicable | Completed | Roswell Park Cancer Institute | 174 | 2006-06-29 | 2021-04-22 |
| Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma epoetin alfa - Anemia, Multiple Myeloma | Not applicable | Completed | The Cleveland Clinic | 31 | 2003-09-01 | 2018-02-22 |
| Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma chemoprotection, complementary or alternative medicine procedure, management of therapy complications - Multiple Myeloma, Plasma Cell Neoplasm | Not applicable | Completed | Fred Hutchinson Cancer Center | 41 | 2003-07-01 | 2011-09-01 |
Neoplasms, Plasma Cell (4) · Multiple Myeloma (3) · Burkitt Lymphoma (2) · Congenital Abnormalities (2) · Hodgkin Disease (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myeloid, Acute (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Immunoblastic (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2) · Lymphoma, T-Cell, Cutaneous (2) · Neuroblastoma (2)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Blood Protein Disorders (3) · Cardiovascular Diseases (3) · Hemorrhagic Disorders (3) · Hemostatic Disorders (3) · Paraproteinemias (3) · Vascular Diseases (3) · Chronic Disease (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)
Busulfan (1) · Carboplatin (1) · Carmustine (1) · Cyclophosphamide (1) · Epoetin Alfa (1) · Etoposide (1) · Melphalan (1) · Therapeutics (1) · Thiotepa (1) · Whole-Body Irradiation (1)
Roswell Park Cancer Institute (2) · Fred Hutchinson Cancer Center (1) · The Cleveland Clinic (1)
United States (3)
Philip McCarthy (2) · Ronald M. Sobecks, MD (1) · William I. Bensinger, MD (1)
P30CA016056 (1), P30CA043703 (1)